NEW YORK, Oct. 4, 2016 /PRNewswire/ -- Complete report
$6,700. DataPack (test
volumes, sales forecasts, supplier shares) $4,300.
VPGMarketResearch.com's new report is a strategic analysis of
major business opportunities emerging in the infectious disease
testing market during the next five years. The report examines key
UK market trends; reviews current and emerging assays; analyzes
potential applications of innovative diagnostic technologies;
forecasts volume and sales for over 100 infectious disease tests by
assay, and market segment; provides test volume estimates by method
(molecular, serology/immunodiagnostics, culture/microscopy);
profiles leading players and potential market entrants; and
suggests alternative business expansion strategies for
suppliers.
Rationale
This comprehensive report will assist diagnostics industry
executives, as well as companies planning to diversify into the
dynamic and rapidly expanding microbiology testing market, in
evaluating emerging opportunities and developing effective business
strategies.
Microbiology testing is one of the most rapidly growing segments
of the in vitro diagnostics industry, and the greatest challenge
facing suppliers during this decade. Among the main driving forces
is continuing spread of AIDS, which remains the world's major
health threat and a key factor contributing to the rise of
opportunistic infections; threat of bioterrorism; advances in
molecular diagnostic technologies; and a wider availability of
immunosuppressive drugs.
Although for some infections the etiology is still a mystery,
while for others the causative microorganisms are present in minute
concentrations long before the occurrence of first clinical
symptoms, recent advances in genetic engineering and detection
technologies are creating exciting opportunities for highly
sensitive, specific and cost-effective products.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation,
reagents kits, IT and other products with significant
market
appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis
Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus,
Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus,
EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes
Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium,
Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses,
Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella,
Salmonella, Septicemia, Shigella, Staphylococci, Streptococci,
Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile,
Yersinia.
Market Segmentation Analysis
- Sales and market shares of major suppliers
by individual test.
- Volume and sales forecasts for over 100 infectious disease
assays by individual test and market segment:
° Hospitals
° Blood Banks
° Commercial/Private Laboratories
° Public Health Laboratories
- Test volume estimates by method (molecular,
serology/immunodiagnostics,
culture/microscopy).
- Review of the market dynamics, trends,
structure, size, growth and major suppliers.
Current and Emerging Products
- In-depth examination of over 100 major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.
Technology Review
- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay, and other technologies and their
potential
applications for infectious disease testing.
- Global listings of companies developing or
marketing infectious disease diagnostic products
by individual test.
Competitive Assessments
- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.
Contains 978 pages and 159 tables
Read the full report:
http://www.reportlinker.com/p04194306-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/uk-virology-and-bacteriology-sales-and-volume-segment-forecasts-for-100-tests-supplier-shares-by-test-innovative-technologies-competitive-strategies-300339312.html
SOURCE Reportlinker